Abstract

Objective: Metabolic syndrome (MetS) is tightly associated with cardiovascular atherosclerosis development and diabetes. However, the association between these markers and glucose intolerance and other clinical parameters in Jordanian MetS patient is not clear. Therefore, the objective of this study was to evaluate the potential association of atherosclerotic/metabolic inflammatory markers in Jordanian MetS patients with their glucose tolerance and other clinical parameters. Methods: A total of 190 MetS obese or overweight subjects (men = 61, women = 129) were enrolled. ELISA assays of plasma hs-CRP, MCP-1, PAI-1, MMP-9, resistin, adiponectin, leptin, MIF, TNF-α, TSP-1, IL-10, and IL-6 were performed. Results: It was found that hs-CRP and TNF-α were significantly and positively correlated with HbA1c (r=0.274; and 0.406; p<0.0001)and FPG (r=0.272; p<0.0001 and r= 0.163; p<0.05) , while IL10 was negatively correlated with HbA1c (r=-0.264; p<0.001). MIF positively correlated with FPG (r=0.207; p<0.001), and along with TSP-1(r=0.580; p<0.0001), it was linked positively to insulin resistance as measured by HOMA-IR (r=0.252; p<0.001). Conclusions: This study showed that most of proinflammatory markers have direct association with indicators of glucose tolerance parameters, namely, FPG and HbA1c. Therefore, these markers can be used as indicators for glucose intolerance and disease progression in patients with metabolic syndrome.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.